Trials / Unknown
UnknownNCT03731923
Abbreviated MRI for HCC Surveillance
MR Value: Clinical Feasibility of Abbreviated MR Protocol for HCC Surveillance in High-risk Group
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 257 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate the clinical feasibility of abbreviated liver MRI for HCC surveillance in a high-risk group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Biannual ultrasonography | Biannual liver ultrasonography for HCC surveillance, without contrast agent. |
| DIAGNOSTIC_TEST | Annual abbreviated liver MRI | Abbreviated liver MRI using standard dose of extracellular contrast agent (Dotarem, Guerbet, France) on weight-based dosing. Table time targets 10 minutes. |
Timeline
- Start date
- 2018-11-08
- Primary completion
- 2021-12-15
- Completion
- 2023-12-31
- First posted
- 2018-11-06
- Last updated
- 2023-08-18
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03731923. Inclusion in this directory is not an endorsement.